Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis
- PMID: 20056222
- PMCID: PMC2884178
- DOI: 10.1016/j.atherosclerosis.2009.11.047
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis
Abstract
Macrophage presence within atherosclerotic plaque is a feature of instability and a risk factor for plaque rupture and clinical events. Activated macrophages express high levels of the translocator protein/peripheral benzodiazepine receptor (TSPO/PBR). In this study, we investigated the potential for quantifying plaque inflammation by targeting this receptor. TSPO expression and distribution in the plaque were quantified using radioligand binding assays and autoradiography. We show that cultured human macrophages expressed 20 times more TSPO than cultured human vascular smooth muscle cells (VSMCs), the other abundant cell type in plaque. The TSPO ligands [3H](R)-1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3-isoquinoline carboxamide ([3H](R)-PK11195) and [3H]N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide ([3H]-DAA1106) bound to the same sites in human carotid atherosclerotic plaques in vitro, and demonstrated significant correlation with macrophage-rich regions. In conclusion, our data indicate that radioisotope-labelled DAA1106 has the potential to quantify the macrophage content of atherosclerotic plaque.
Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.
Figures

Similar articles
-
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.Cardiovasc Diabetol. 2018 Feb 20;17(1):31. doi: 10.1186/s12933-018-0675-2. Cardiovasc Diabetol. 2018. PMID: 29463262 Free PMC article.
-
Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors.Eur J Pharmacol. 1999 Apr 29;371(2-3):197-204. doi: 10.1016/s0014-2999(99)00118-1. Eur J Pharmacol. 1999. PMID: 10357257
-
N-Benzyl-N-methyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide.2010 May 6 [updated 2010 Aug 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 May 6 [updated 2010 Aug 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20734501 Free Books & Documents. Review.
-
N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[131I]iodo-5-methoxybenzyl)acetamide.2007 Aug 6 [updated 2007 Sep 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Aug 6 [updated 2007 Sep 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641364 Free Books & Documents. Review.
-
N-Benzyl-N-ethyl-2-[7,8-dihydro-7-(2-[18F]fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide.2010 May 6 [updated 2010 Aug 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 May 6 [updated 2010 Aug 19]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20734500 Free Books & Documents. Review.
Cited by
-
Molecular Imaging of Inflammatory Disease.Biomedicines. 2021 Feb 4;9(2):152. doi: 10.3390/biomedicines9020152. Biomedicines. 2021. PMID: 33557374 Free PMC article. Review.
-
PET imaging of inflammation in atherosclerosis.Nat Rev Cardiol. 2014 Aug;11(8):443-57. doi: 10.1038/nrcardio.2014.80. Epub 2014 Jun 10. Nat Rev Cardiol. 2014. PMID: 24913061 Review.
-
Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism.J Nucl Med. 2021 Apr;62(4):536-544. doi: 10.2967/jnumed.120.243600. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859708 Free PMC article.
-
Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.World J Cardiol. 2015 May 26;7(5):277-86. doi: 10.4330/wjc.v7.i5.277. World J Cardiol. 2015. PMID: 26015858 Free PMC article. Review.
-
Translocator Protein Modulation by 4'-Chlorodiazepam and NO Synthase Inhibition Affect Cardiac Oxidative Stress, Cardiometabolic and Inflammatory Markers in Isoprenaline-Induced Rat Myocardial Infarction.Int J Mol Sci. 2021 Mar 11;22(6):2867. doi: 10.3390/ijms22062867. Int J Mol Sci. 2021. PMID: 33799869 Free PMC article.
References
-
- Fuster V., Stein B., Ambrose J.A. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation. 1990;82:II47–II59. - PubMed
-
- Libby P., Geng Y.J., Aikawa M. Macrophages and atherosclerotic plaque instability. Curr Opin Lipidol. 1996;7:330–335. - PubMed
-
- Rudd J.H., Myers K.S., Bansilal S. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871–878. - PubMed
-
- Tawakol A., Migrino R.Q., Bashian G.G. In vivo 18F-flurodeoxyglucose positron emission tomography imaging provides a non-invasive measure of carotid plaque inflammation in patients. J Am Acad Cardiol. 2006;48:1818–1824. - PubMed
-
- Rudd J.H.F., Warburton E.A., Fryer T.D. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–2711. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical